Company / Tangible Book Value per Share
Integra Lifesciences Holdings Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$5.33
FY2025
5-year range
$5.33 / $8.98
FY2021-FY2025
Trend
-0.7%
vs FY2024
Sector context
#76 of 158
Health Care
What the data says
At $5.33, Integra Lifesciences Holdings's tangible book value per share ranks #76 of 158 in the Health Care sector. Tangible Book Value per Share has declined for 3 consecutive years, from $8.98 in FY2022 to $5.33 in FY2025.
Based on SEC 10-K filings.
5.33 in FY2025 with a 5-year CAGR of -5.1%.
Declined from $6.23 to $5.33 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -16.0%
- 5-Year CAGR
- -5.1%
- 10-Year CAGR
- -
Sector benchmark
#76 of 158 in Health CareTop 48% of 158This company $5.33 Sector average $18.47
▼
-71.1% below sector average
Key checks
Key Insights
- Integra Lifesciences Holdings's tangible book value per share has declined for 3 consecutive years.
- In FY2025, tangible book value per share decreased 0.7% year-over-year.
- Ranks #76 out of 158 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.33 | -0.7% |
| FY2024 | $5.37 | -13.8% |
| FY2023 | $6.23 | -30.7% |
| FY2022 | $8.98 | +15.7% |
| FY2021 | $7.76 | +11.9% |
| FY2020 | $6.93 | +18.6% |
| FY2019 | $5.84 | +3.0% |
| FY2018 | $5.67 | +68.1% |
| FY2017 | $3.38 | +15.9% |
| FY2016 | $2.91 | -64.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026